StocksFin Logo
ACAD logo
$ACAD

ACADIA Pharmaceuticals Inc.

ACAD country of incorporation
|
https://www.acadia-pharm.com
|
Mr. Stephen Davis
|
510 employees
NASDAQ | Healthcare | Biotechnology
ACAD reported its Q322 earnings on November 3, 2022 (101 weeks ago).
$130.71M -0.7% vs. Q321 Revenues Q322
98.37% 3.6% vs. Q321 Gross Profit Margin
-20.8% ! -89.3% vs. Q321 Net Profit Margin
-727k ! 95.7% vs. Q321 Free Cash Flow Q322
$-0.17 ! -88.9% vs. Q321 EPS Q322
Company Card Q322
As reported on November 3, 2022
Is profitable?
Has Revenue Growth?
Has Net Profit Growth?
Has FCF Growth?
Has OCF Growth?
Has EPS Growth?
Pays a Dividend?
Rating
B-
Growth calculated YoY
Company Card Q322
As reported on November 3, 2022
Is profitable?
Has Revenue Growth?
Has Net Profit Growth?
Has FCF Growth?
Has OCF Growth?
Has EPS Growth?
Pays a Dividend?
Rating
B-
Growth calculated YoY
Overview
Income Statement
Full Income Statement
Period Net Revenue Cost of Revenue Net Profit EPS
FY2022 Not reported yet.
Q32022
130.71M
-2.9%
2.14M
-27.18M
+20.1%
$-0.17
Q22022
134.56M
+16.5%
2.67M
-34.01M
+69.9%
$-0.21
Q12022
115.47M
2.95M
-113.06M
$-0.7
FY2021
484.15M
 19.14M
-167.87M
$-1.07
Q42021
130.76M
-0.6%
2.56M
-43.09M
-198.1%
$-0.27
Q32021
131.61M
+14.2%
6.68M
-14.46M
+67%
$-0.09
Q22021
115.22M
+8.1%
5.21M
-43.87M
+34%
$-0.27
Q12021
106.55M
4.69M
-66.45M
$-0.42
FY2020
441.76M
 20.55M
-281.58M
$-1.79
FY2019
339.08M
 19.6M
-235.26M
$-1.6
FY2018
223.81M
 18.33M
-245.19M
$-1.94
Balance Sheet
Full Balance Sheet
Period Total Assets Total Liabilities Cash & Eq. Debt Stock Equity
FY2022 Not reported yet.
Q32022
602.49M
 176.81M
154.84M
63M
425.69M
Q22022
612.77M
 177.92M
139.83M
63.72M
434.85M
Q12022
624.25M
 179.45M
204.92M
64.42M
444.8M
FY2021
700.12M
 159.23M
147.44M
72.73M
540.89M
FY2020
782.62M
 155.61M
326.03M
54.63M
627.01M
FY2019
783.18M
 84.05M
189.68M
13.23M
699.14M
FY2018
540.2M
 61.12M
134.76M
0
479.08M
Cash Flow Statement
Full Cash Flow Statement
Period Operating CF Investing CF Financing CF Capex Free Cash Flow
FY2022 Not reported yet.
Q32022
-727k
 15.44M
287k
0
-727k
+94.5%
Q22022
-13.13M
 -55.8M
3.83M
0
-13.13M
+82.8%
Q12022
-76.33M
 131.35M
2.47M
0
-76.33M
FY2021
-125.66M
 -71.1M
18.16M
-1.12M
-126.78M
FY2020
-136.17M
 192.51M
81M
-7.59M
-143.75M
FY2019
-151.13M
 -165.84M
371.85M
-1.13M
-152.26M
FY2018
-167.47M
 -71.49M
306.65M
-2.15M
-169.62M
Institutional Ownership
Dividend History
No dividend history.
Number of Employees